Studies have shown that the increase of mature DC cells caused by Poly-ICLC in combination with EGFR-targeted drugs can increase EGFR-targeted CD8+ T cells in NPC cells, thus providing a better prognosis for NPC [95]. The gene discussed is CD8A; the disease is nasopharyngeal carcinoma.